Statistics for Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer

Total visits

views
Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer 497

Total visits per month

views
May 2024 1
June 2024 0
July 2024 1
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
Peery_iupui_0104D_10414.pdf 240

Top country views

views
United States 168
China 38
United Kingdom 15
Germany 6
India 6
Ukraine 5
Canada 3
France 3
Poland 3
Czechia 2
Hong Kong SAR China 2
Netherlands 2
Russia 2
Vietnam 2
Australia 1
Brazil 1
Denmark 1
Spain 1
Finland 1
Indonesia 1
Israel 1
Iran 1
Italy 1
South Korea 1
Malaysia 1
Philippines 1
Romania 1
Serbia 1
British Virgin Islands 1

Top city views

views
Wilmington 56
Guanglian 21
Washington 20
Houston 13
Ann Arbor 8
Calhoun 6
White Plains 6
Lake Mary 5
Liverpool 5
Caldwell 4
Fairfield 4
Jacksonville 4
Kiev 4
San Francisco 4
Kiez 3
Beijing 2
Cambridge 2
Cesson 2
Chicago 2
Coimbatore 2
Dong Ket 2
Guangzhou 2
Gunzenhausen 2
Idar 2
Kansas City 2
Oakland 2
Palo Alto 2
Parsippany 2
Pionki 2
San Jose 2
Toronto 2
Utrecht 2
Ashburn 1
Azad 1
Baltimore 1
Bat Yam 1
Belgrade 1
Bridge 1
Brighton 1
Buffalo 1
Central District 1
Chongqing 1
Dayton 1
Edinburgh 1
Hangzhou 1
Helsinki 1
Honeybourne 1
Indianapolis 1
Jakarta 1
Kanda 1
Kharkov 1
Kuala Lumpur 1
Las Vegas 1
León 1
London 1
Monmouth Junction 1
Moscow 1
Mount Juliet 1
Mount Laurel 1
Mumbai 1
Newtown 1
Norristown 1
Norwich 1
Omaha 1
Ottawa 1
Oxford 1
Petrosani 1
Philadelphia 1
Poplar 1
Præstø 1
Reading 1
Roubaix 1
Saint Petersburg 1
San Mateo 1
Seoul 1
Shenzhen 1
Slapanice 1
Stillwater 1
Stuttgart 1
São Paulo 1
Toledo 1
Warsaw 1
Woburn 1